Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT03537807 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03537807
Sponsor: Biohaven Pharmaceuticals, Inc.
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Amyotrophic Lateral Sclerosis ALS Lou Gehrig Disease Lou Gehrig's Disease Lou-Gehrigs Disease Motor Neuron Disease, Amyotrophic Lateral Sclerosis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.